Sign In

Max Mikheev

CEO/co-founder at BioMediCan, Inc (LION-LinkedIn open networker)

Max Mikheev is the CEO and Founder of BioMediCan, Inc., a biotechnology company based in the San Francisco Bay Area.3 Here are some key details about Max Mikheev's background and experience:

Education and Early Career

Max Mikheev has an extensive educational background in molecular biology and medicine:

  • PhD in Molecular Biology from the State Research Center of Virology and Biotechnology "Vector" (1998-2006)3
  • MD in Clinical and Laboratory Diagnostics from Novosibirsk State Medical University (1999-2004)3
  • M.Sc. in Molecular Biology from Novosibirsk State University (1994-1999)3

Professional Experience

BioMediCan, Inc.:

  • Founder and CEO since November 20173
  • The company focuses on developing production of high-value compounds through biosynthesis3

Previous Roles::

  • Co-founder of Viar.Live, a VR software startup (2015-2017)3
  • CTO and Co-founder of BioDatomics, a life sciences startup focused on big data analytics for genomics (2012-2017)3
  • Postdoctoral Research Fellow at University of Pittsburgh School of Medicine (2008-2011)3
  • Postdoctoral Research Fellow at National Institute on Aging (2006-2008)3

Expertise and Achievements

  • Over 22 years of experience in genomics4
  • Co-inventor of multiple patent applications related to genetic modifications4
  • Co-founded BioDatomics, the first Hadoop-based big data genomic analysis platform4
  • Co-founded BioSoft RU, a genomic pathways software startup4

Current Work at BioMediCan

At BioMediCan, Max Mikheev and his team have developed a cutting-edge biotechnology method called Biosynthesis.2 This method has revolutionized the production of high-value compounds like CBG, THCA, THCV, CBN, and rare cannabinoids.2 The company uses genetically optimized yeast to produce pharmaceutically pure cannabinoids that are identical to those found in nature, but at a fraction of the cost.2

Max Mikheev's role as CEO and Chief Science Officer involves shaping the company's scientific strategy and overseeing its research and development efforts.14 While he prefers to focus on the scientific aspects of the job, he has also played a significant role in raising capital for the company and working with investors.2

Highlights

Jun 14 · linkedin

Sensors Converge is just around the corner! I'm excited to attend June 24-26 in Santa Clara, CA to experience North America's largest electronics event for design engineers. This year's event is gearing up to be the place to see the latest technologies, hear from the top experts, and connect with the industry for sensing, processing, and connectivity.

Join me: https://lnkd.in/gexSW9xv - use code JOINME for $100 off Conference and VIP passes or a FREE Expo Hall Pass.

#SensorsConverge #electronics #IoT #sensors #embedded #processing #connectivity Questex

Aug 17 · linkedin

Dennis O'Neill and I are hosting an online event for Biomedican investors: https://lnkd.in/gCV-zFZy Please join if you are looking for new investment opportunities and are interested in biotechnology for producing 100% organic medical cannabinoids. #biotech #biotechnology #lifesciences #investment #marketresearch #cbd #cannabinoids

Related Questions

What are the main achievements of Max Mikheev at BioMediCan?
How did Max Mikheev's experience at BioDatomics influence his work at BioMediCan?
What are the key innovations BioMediCan is working on under Max Mikheev's leadership?
How does BioMediCan's approach to biosynthesis differ from traditional agriculture?
What challenges has Max Mikheev faced in his career in biotechnology?
Max Mikheev
Max Mikheev, photo 1
Max Mikheev, photo 2
Add to my network

Location

San Francisco Bay Area